AzTrials
AzTrials

Diabetes MellitusNCT06727123

The Effect of Motivational Interviewing on Diabetes Self-Management in Diabetic Patients

A study testing motivational interviewing in people with Diabetes Mellitus, run by University of Beykent at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Diabetes is a chronic metabolic disorder characterized by high blood sugar due to problems with insulin production or function. Its prevalence has increased significantly in recent decades due to sedentary lifestyles, unhealthy diets, and increasing obesity rates. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Diabetes Mellitus
What is being tested?
motivational interviewing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteTurkey (Türkiye)
Study dates
20 Dec 2024to 20 Jun 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Individuals who agree to participate in the study voluntarily, can speak and understand Turkish, can communicate comfortably, have no hearing, comprehension or vision problems, are literate, use a smartphone, have Type 2 Diabetes and have HbA1c ≥ 7% will be included in the study.

Who cannot join

  • Patients with cognitive dysfunction and those using antipsychotic medication will not be included.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site
  • Istanbul Beykent University

    Istanbul

    Sule Ç Calisir Kundakci, RN, +905467873906, sulecalisir@gmail.com

    Sule Calisir Kundakci, RN

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Motivational Interviewing on Diabetes Self-Management in Type 2 Diabetic Patients

Diabetes is a chronic metabolic disorder characterized by high blood sugar due to problems with insulin production or function. Its prevalence has increased significantly in recent decades due to sedentary lifestyles, unhealthy diets, and increasing obesity rates. Type 2 diabetes, in particular, is a major global and national health problem with projections showing that it continues to grow. Effective diabetes management requires patients to adopt healthy behaviors such as following a diet plan, monitoring blood sugar, increasing physical activity, and avoiding risky habits such as smoking. Inadequate adherence to treatment can lead to serious complications such as cardiovascular disease and kidney damage, which can be a burden to patients, families, and healthcare systems. Motivational interviewing, a patient-centered approach, helps individuals overcome resistance to behavioral change. This study was designed experimentally to determine the effect of motivational interviewing on diabetes self-management in patients with type 2 diabetes.

Read the detailed description

Diabetes is defined as a chronic metabolic disorder characterized by high blood sugar levels. Abnormalities in insulin production, function, or both are considered the primary causes of the disease. The epidemiology of diabetes has changed significantly over the last three decades. Diabetes mellitus is one of the most important health problems for both patients and society due to its high mortality, morbidity, and associated costs. The prevalence of diabetes continues to increase globally, driven by advances in technology, sedentary lifestyles, and increasing rates of obesity. Among these factors, the shift towards less active lifestyles plays a central role, with many individuals spending long periods sitting or engaging in low-energy activities. In addition, poor dietary habits, including increased consumption of high-calorie, processed foods, have increased the risk of developing diabetes, especially type 2 diabetes. In Turkey, the prevalence of type 2 diabetes reported in 2020 has shown a significant increase and is expected to increase further by 2050 if current trends continue. Effective treatment for diabetes requires patients to adopt positive attitudes and behaviors towards managing their health. However, many individuals have difficulty maintaining long-term lifestyle changes. Poor adherence to treatment plans and poor disease management often lead to a variety of complications, including acute and chronic health problems. These complications, such as cardiovascular disease, neuropathy, and kidney damage, impose a significant caregiving burden on individuals with diabetes, their families, and society as a whole. To alleviate these problems, individuals must engage in effective self-management to control their disease and prevent complications. Self-management refers to the individual's responsibility to maintain and improve their health. Diabetes self-management aims to normalize blood sugar levels and reduce the risk of long-term complications. Key practices include developing a personalized nutrition plan, monitoring blood sugar levels, maintaining metabolic control, increasing physical activity, and avoiding risky behaviors such as smoking or excessive alcohol consumption. Despite its importance, individuals living with diabetes often face challenges in adopting the lifestyle, behavioral, and psychological changes necessary for effective management. Motivational interviewing is an evidence-based approach that helps individuals resolve the dilemma of behavioral change and facilitates treatment adherence for chronic conditions such as diabetes. This patient-centered method emphasizes understanding the patient's unique challenges and goals, tailoring strategies to their specific needs, and encouraging autonomy. This study aims to evaluate the impact of motivational interviewing on diabetes self-management in patients with type 2 diabetes. It seeks to understand whether this approach can improve health outcomes by encouraging better adherence to treatment plans and supporting sustainable behavioral change, ultimately enhancing disease management in individuals coping with diabetes.

Being tested
motivational interviewing, Control
Keywords
Diabetes Mellitus
Medical subject headings
Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • motivational interviewingOther

    Motivational interviews will be conducted with diabetic patients for 6 months. Patients will be trained before starting the interviews.

  • ControlOther

    No application will be made. Routine follow-ups will be made.

Study groups in NCT06727123
Study groupRoleWhat they receive
Motivational InterviewingExperimentalMotivational interviews will be conducted with diabetic patients for 6 months. Patients will be trained before starting the interviews.
Receives: Other: motivational interviewing
ControlExperimentalNo application will be made. Routine follow-ups will be made.
Receives: Other: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diabetes Self-Management

    Type 2 Diabetes Self-Management Scale

    Measured: 6 months

Secondary outcomes (1)
  1. HbA1c

    Routine blood value monitoring

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2024
  2. Study start20 Dec 2024 (estimated)
  3. Primary completion20 Dec 2025 (estimated)
  4. Study completion20 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06727123
Sponsor's protocol ID
SCK22T24
Status last verified
Dec 2024
First submitted
6 Dec 2024
Last updated
10 Dec 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing motivational interviewing in people with Diabetes Mellitus, run by University of Beykent at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 10 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diabetes Self-Management (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in